Abstract
Background: The presence of the class I integron gene is associated with the emergence of multiple drug resistance (MDR) phenotype in Pseudomonas aeruginosa (P. aeruginosa) isolates.
Aim: The objectives of this research were to study the prevalence of integrase genes I (Intel I) and integrase genes II (Intel II) in clinical isolates of P. aeruginosa and its association with antibiotic resistance in these isolates.
Methods: The study was a retrograde cross-sectional study that was carried out on 150 clinical isolates of P. aeruginosa isolated from patients with healthcare-associated infections. The isolates were subjected to biochemical identification and antibiotic sensitivity study by discs diffusion test. Intel I & Intel II genes were detected by polymerase chain reaction (PCR).
Results: Intel I gene was present in 48% of the isolates, and Intel II was present in 1.3% of the isolates. Intel I gene was detected at a statistically significant high rate in MDR- P. aeruginosa (76.9%, P=0.001) compared to non-MDR- P. aeruginosa (3.4%), while intel II had a statistically insignificant increase in MDR- P. aeruginosa (1.1%, P=1.00) compared to non-MDR-P. aeruginosa (1.7%). Both Intl I/Intl II genes were detected in 2.2% of MDR-P. aeruginosa isolates and were absent in non- MDR-P. aeruginosa isolates with statistically insignificant difference (P=1.00). P. aeruginosa isolates with Intel I gene had an increase in antibiotic resistance pattern to the used antibiotics discs. However, this increase had statistically significant rates only for gentamicin (63.9%, P≤0.001), meropenem (47.2%, P=0.009), trimethoprim/sulfamethoxazole (37.5%, P=0.013) and imipenem (44.4%, P=0.025).
Conclusion: The present study highlights the high prevalence of the Intel I gene in clinical isolates of P. aeruginosa, while the Intel II gene was less prevalent in these isolates. There was a significant association between the prevalence of the Intel I gene and the MDR phenotype of P. aeruginosa and resistance to gentamicin, meropenem, trimethoprim/sulfamethoxazole, and imipenem. These findings need future evaluation in a higher number of clinical isolates of P. aeruginosa.
Keywords: P. aeruginosa, integrase I gene, integrase II gene, multiple drug resistance, gentamicin, integrons.
[http://dx.doi.org/10.4236/ojmm.2016.62012]
[http://dx.doi.org/10.4172/2155-9597.1000199]
[http://dx.doi.org/10.1086/338782] [PMID: 11823954]
[http://dx.doi.org/10.1128/MMBR.00016-10] [PMID: 20805405]
[http://dx.doi.org/10.2174/1874285801610010188] [PMID: 28077975]
[http://dx.doi.org/10.2174/1874285801913010063]
[http://dx.doi.org/10.1016/j.ijantimicag.2011.06.014] [PMID: 21873034]
[http://dx.doi.org/10.1007/s00203-011-0744-3] [PMID: 21842348]
[http://dx.doi.org/10.22038/ijbms.2020.48905.11208]
[PMID: 24551780]
[http://dx.doi.org/10.1128/AAC.46.9.2948-2955.2002] [PMID: 12183252]
[http://dx.doi.org/10.1016/j.tim.2019.12.002] [PMID: 31948729]
[http://dx.doi.org/10.13140/RG.2.2.23860.40328]
[http://dx.doi.org/10.1186/s12348-021-00268-w] [PMID: 34585284]
[http://dx.doi.org/10.1128/JCM.39.1.8-13.2001] [PMID: 11136740]
[http://dx.doi.org/10.1016/j.gendis.2019.04.001]
[http://dx.doi.org/10.2807/ese.15.41.19688-en] [PMID: 20961515]
[http://dx.doi.org/10.7573/dic.212527] [PMID: 29872449]
[http://dx.doi.org/10.1016/j.ajic.2014.08.006] [PMID: 25444305]
[http://dx.doi.org/10.22038/ijbms.2019.35063.8340] [PMID: 32373303]
[http://dx.doi.org/10.1590/S0037-86822012005000003] [PMID: 22767099]
[http://dx.doi.org/10.1371/journal.pone.0176774] [PMID: 28481953]
[http://dx.doi.org/10.7416/ai.2018.2202] [PMID: 29465148]
[http://dx.doi.org/10.1371/journal.pone.0183061]
[http://dx.doi.org/10.1086/345880] [PMID: 12552449]